Brief: PLx Pharma Provides Regulatory Update On Vazalore

PLx Pharma Winddown

06/01/2020 12:14

Jan 6 (Reuters) - PLx Pharma Inc  PLXP.O :
    * PLX PHARMA INC. PROVIDES REGULATORY UPDATE ON VAZALORE
    * PLX PHARMA INC - EXPECT TO LAUNCH VAZALORE IN LATE 2020
    * PLX PHARMA - FDA HAS APPROVED UPDATED LABELING FOR 325 MG
DOSE
STRENGTH
    * PLX PHARMA - WILL APPLY APPROVED 325 MG LABELING TO 81 MG
LABELING IN CMC SUBMISSION PLANNED FOR Q2 2020
    * PLX PHARMA - IN RECENT INTERACTIONS WITH FDA, AGREED TO
PROVIDE
SOME ADDITIONAL DATA ON VAZALORE 325 MG DOSE STRENGTH
    * PLX PHARMA - EXPECTS TO MEET WITH FDA TO FINALIZE DATA
MODELING
COMPONENTS SHORTLY
    * PLX PHARMA - ANTICIPATES COMPLETING DATA MODELING AND
SUBMISSIONS FOR BOTH VAZALORE 325 MG AND VAZALORE 81 MG
SIMULTANEOUSLY IN Q2 OF 2020
    * PLX PHARMA SEES LAUNCH OF BOTH DOSAGES OF VAZALORE IN
UNITED
STATES TOWARDS END OF 2020

Source text for Eikon:  ID:nGNX7pnFjR 
Further company coverage:  PLXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))